Evidence map›Paper›PMID 30402539›Full record

ArticleScience advances2018

Universal intracellular biomolecule delivery with precise dosage control.

Y Cao, H Chen, R Qiu, M Hanna, E Ma, M Hjort, A Zhang, R S Lewis, J C Wu, N A Melosh

Abstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Poking Pluripotency: Nanoinjection Into Human iPSCs.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  6. Article
  7. Just a little prick: careful cell contacts enabled by ceramic nanostraws.Pflugers Archiv : European journal of physiology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Single molecule delivery into living cells.Nature communications · 2024
    Article
  14. Article
  15. Article
  16. Recent advances in single-cell subcellular sampling.Chemical communications (Cambridge, England) · 2023
    Review
  17. Type-Independent 3D Writing and Nano-Patterning of Confined Biopolymers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Y CaoDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-2376-5626
H ChenStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-2798-0478
R QiuDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-9484-4375
M HannaDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.
E MaDepartment of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA.
M HjortDivision of Synchrotron Radiation Research and Nanometer Structure Consortium, Lund University, Lund, Sweden.
A ZhangStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-0906-6770
R S LewisDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
J C WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-6068-8041
N A MeloshDepartment of Materials Science and Engineering, Stanford University, Stanford, CA 94305, USA.

Funding

Ion Channels and Signaling Mechanisms in T LymphocytesR37GM045374 · NIGMS · STANFORD UNIVERSITY · PI LEWIS, RICHARD S · 2012 to 2021
$6.2M
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico ModelingR01HL128170 · NHLBI · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO, CLANCY, COLLEEN E · 2015 to 2018
$3.0M
Molecular Imaging of Cardiac Pluripotent Stem CellsR01HL133272 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2016 to 2020
$2.4M
Using Deep Learning to Predict Induced Pluripotent Stem Cell-Derived Cardiomyocyte (iPSC-CM) Differentiation OutcomesF30HL156478 · NHLBI · STANFORD UNIVERSITY · PI ZHANG, ANGELA · 2021 to 2023
$118k
NHLBI NIH HHS F30 HL156478NHLBI NIH HHS R01 HL128170NHLBI NIH HHS R01 HL133272NIGMS NIH HHS R37 GM045374
6 · The paper itself

Abstract

Intracellular delivery of mRNA, DNA, and other large macromolecules into cells plays an essential role in an array of biological research and clinical therapies. However, current methods yield a wide variation in the amount of material delivered, as well as limitations on the cell types and cargoes possible. Here, we demonstrate quantitatively controlled delivery into a range of primary cells and cell lines with a tight dosage distribution using a nanostraw-electroporation system (NES). In NES, cells are cultured onto track-etched membranes with protruding nanostraws that connect to the fluidic environment beneath the membrane. The tight cell-nanostraw interface focuses applied electric fields to the cell membrane, enabling low-voltage and nondamaging local poration of the cell membrane. Concurrently, the field electrophoretically injects biomolecular cargoes through the nanostraws and into the cell at the same location. We show that the amount of material delivered is precisely controlled by the applied voltage, delivery duration, and reagent concentration. NES is highly effective even for primary cell types or different cell densities, is largely cargo agnostic, and can simultaneously deliver specific ratios of different molecules. Using a simple cell culture well format, the NES delivers into >100,000 cells within 20 s with >95% cell viability, enabling facile, dosage-controlled intracellular delivery for a wide variety of biological applications.

Indexed as

Drug Delivery SystemsCell MembraneElectroporationGreen Fluorescent ProteinsHEK293 CellsHumansNanostructuresNanotechnologyNeoplasm ProteinsRNA, MessengerStromal Interaction Molecule 1Green Fluorescent ProteinsNeoplasm ProteinsRNA, MessengerSTIM1 protein, humanStromal Interaction Molecule 1

Identifiers

PMID30402539
PMCPMC6209385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.